Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
IQVIA Hldgs
(NYSE:IQV)
Intraday
$240.22
1.60
[0.67%]
15 minutes delayed
Get Report
Watch
Perks
Buy
Compare Brokers
$240.22
1.60
[0.67%]
Last update: 2:59PM
Get Real Time Here
Get Report
Watch
Q1 2024 Earnings in 8 days from now on Thu May 2nd, before the market open
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for IQVIA Hldgs Stock (NYSE:IQV)
IQVIA Hldgs Stock (NYSE: IQV)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Tuesday, April 23, 2024
Shares of life sciences tools stocks are trading higher following strong earnings from Danaher.
Benzinga Newsdesk
-
1 day ago
Tuesday, April 09, 2024
Salesforce & IQVIA Expand Partnership: Life Sciences Cloud Gets A Superpower Boost
Lekha Gupta
-
Apr 9, 2024, 10:03AM
Monday, April 08, 2024
IQVIA and Salesforce Expand Global Partnership To Accelerate The Development Of Life Sciences Cloud
Benzinga Newsdesk
-
Apr 8, 2024, 4:01PM
Friday, March 29, 2024
Peering Into IQVIA Hldgs's Recent Short Interest
Benzinga Insights
-
Mar 29, 2024, 11:00AM
Thursday, March 14, 2024
IQVIA Hldgs's Options Frenzy: What You Need to Know
Benzinga Insights
-
Mar 14, 2024, 10:46AM
Wednesday, March 13, 2024
Peering Into IQVIA Hldgs's Recent Short Interest
Benzinga Insights
-
Mar 13, 2024, 1:00PM
Tuesday, February 27, 2024
Truist Securities Maintains Buy on IQVIA Hldgs, Raises Price Target to $297
Benzinga Newsdesk
-
Feb 27, 2024, 8:59AM
Monday, February 26, 2024
Leerink Partners Initiates Coverage On IQVIA Hldgs with Outperform Rating, Announces Price Target of $290
Benzinga Newsdesk
-
Feb 26, 2024, 9:10AM
Thursday, February 15, 2024
How Is The Market Feeling About IQVIA Hldgs?
Benzinga Insights
-
Feb 15, 2024, 11:00AM
Guggenheim Downgrades IQVIA Hldgs to Neutral
Benzinga Newsdesk
-
Feb 15, 2024, 8:05AM
Wednesday, February 14, 2024
Stocks Rebound As Investor Focus Shifts To Earnings, Bitcoin Tops $1 Trillion Value: What's Driving Markets Wednesday?
Piero Cingari
-
Feb 14, 2024, 1:51PM
Healthcare Analytics-Focused IQVIA Says 2023 Performance Solid Despite Challenging Macro Environment
Vandana Singh
-
Feb 14, 2024, 11:26AM
Charles River Laboratories International Posts Upbeat Results, Joins Robinhood, Zillow, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesday
Avi Kapoor
-
Feb 14, 2024, 10:36AM
IQVIA shares are trading higher after the company reported better than expected Q4 2023 earnings and issued 2024 guidance.
Benzinga Newsdesk
-
Feb 14, 2024, 7:11AM
IQVIA Forecasts 2024 Revenue Of $15.4B-$15.65B And Adjusted EPS Of $10.95-$11.25, Versus Consensus Of $15.60B And $11.08, Respectively
Benzinga Newsdesk
-
Feb 14, 2024, 7:10AM
IQVIA Hldgs Q4 Adjusted EPS $2.84 Beats $2.82 Estimate, Sales $3.87B Beat $3.79B Estimate
Benzinga Newsdesk
-
Feb 14, 2024, 7:04AM
Earnings Scheduled For February 14, 2024
Benzinga Insights
-
Feb 14, 2024, 4:48AM
Tuesday, February 13, 2024
Peeling Back The Layers: Exploring IQVIA Hldgs Through Analyst Insights
Benzinga Insights
-
Feb 13, 2024, 8:00AM
BTIG Initiates Coverage On IQVIA Hldgs with Buy Rating, Announces Price Target of $285
Benzinga Newsdesk
-
Feb 13, 2024, 7:16AM
Thursday, January 25, 2024
Expert Ratings For IQVIA Hldgs
Benzinga Insights
-
Jan 25, 2024, 10:00AM
Barclays Maintains Overweight on IQVIA Hldgs, Raises Price Target to $260
Benzinga Newsdesk
-
Jan 25, 2024, 9:50AM
Thursday, January 18, 2024
Baird Maintains Neutral on IQVIA Hldgs, Raises Price Target to $226
Benzinga Newsdesk
-
Jan 18, 2024, 2:17PM
Monday, January 08, 2024
(IQV) - Analyzing IQVIA Hldgs's Short Interest
Benzinga Insights
-
Jan 8, 2024, 1:00PM
Thursday, January 04, 2024
IQVIA Hldgs Stock: A Deep Dive Into Analyst Perspectives (11 Ratings)
Benzinga Insights
-
Jan 4, 2024, 2:00PM
Truist Securities Maintains Buy on IQVIA Hldgs, Raises Price Target to $286
Benzinga Newsdesk
-
Jan 4, 2024, 11:27AM
Tuesday, January 02, 2024
IQVIA's Bold Merger Move Blocked As FTC's Concerns Over Competition Take Center Stage
Nabaparna Bhattacharya
-
Jan 2, 2024, 6:55AM
Friday, December 22, 2023
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Benzinga Insights
-
Dec 22, 2023, 9:30AM
Monday, December 18, 2023
How Is The Market Feeling About IQVIA Hldgs?
Benzinga Insights
-
Dec 18, 2023, 1:45PM
Thursday, December 14, 2023
$1000 Invested In IQVIA Hldgs 5 Years Ago Would Be Worth This Much Today
Benzinga Insights
-
Dec 14, 2023, 10:01AM
Monday, December 11, 2023
The Latest Analyst Ratings for IQVIA Hldgs
Benzinga Insights
-
Dec 11, 2023, 8:00AM
Citigroup Maintains Neutral on IQVIA Hldgs, Raises Price Target to $225
Benzinga Newsdesk
-
Dec 11, 2023, 7:08AM
Thursday, November 30, 2023
Looking Into IQVIA Hldgs's Recent Short Interest
Benzinga Insights
-
Nov 30, 2023, 1:00PM
Tuesday, November 28, 2023
Price Over Earnings Overview: IQVIA Hldgs
Benzinga Insights
-
Nov 28, 2023, 1:15PM
Tuesday, November 21, 2023
Analyst Ratings for IQVIA Hldgs
Benzinga Insights
-
Nov 21, 2023, 3:00PM
Truist Securities Reiterates Buy on IQVIA Hldgs, Maintains $240 Price Target
Benzinga Newsdesk
-
Nov 21, 2023, 2:08PM
Monday, November 13, 2023
JP Morgan Maintains Overweight on IQVIA Hldgs, Lowers Price Target to $239
Benzinga Newsdesk
-
Nov 13, 2023, 10:53AM
Tuesday, November 07, 2023
Peering Into IQVIA Hldgs's Recent Short Interest
Benzinga Insights
-
Nov 7, 2023, 10:15AM
Friday, November 03, 2023
Morgan Stanley Maintains Overweight on IQVIA Hldgs, Lowers Price Target to $225
Benzinga Newsdesk
-
Nov 3, 2023, 9:00AM
The Latest Analyst Ratings for IQVIA Hldgs
Benzinga Insights
-
Nov 3, 2023, 8:00AM
Thursday, November 02, 2023
Guggenheim Maintains Buy on IQVIA Hldgs, Lowers Price Target to $220
Benzinga Newsdesk
-
Nov 2, 2023, 4:34PM
Truist Securities Maintains Buy on IQVIA Hldgs, Lowers Price Target to $240
Benzinga Newsdesk
-
Nov 2, 2023, 3:52PM
Barclays Maintains Overweight on IQVIA Hldgs, Lowers Price Target to $215
Benzinga Newsdesk
-
Nov 2, 2023, 11:22AM
Baird Downgrades IQVIA Hldgs to Neutral, Lowers Price Target to $202
Benzinga Newsdesk
-
Nov 2, 2023, 8:27AM
Wednesday, November 01, 2023
Healthcare Analytics Solutions Provider IQVIA Cuts Annual Forecast, Sees Demand Slowing For Services
Vandana Singh
-
Nov 1, 2023, 1:47PM
Earnings Scheduled For November 1, 2023
Benzinga Insights
-
Nov 1, 2023, 7:19AM
IQVIA Forecasts Q4 FY23 Revenue Of $3.769B-$3.804B Versus Consensus Of $3.96B
Benzinga Newsdesk
-
Nov 1, 2023, 7:14AM
IQVIA Forecasts Q4 FY23 Adjusted EPS Of $2.79-2.86 Versus Consensus Of $2.94
Benzinga Newsdesk
-
Nov 1, 2023, 7:14AM
IQVIA Forecasts FY23 Adjusted EPS Of $10.16-$10.23 Versus Prior Guidance Of $10.20-$10.45 And Consensus Of $10.29
Benzinga Newsdesk
-
Nov 1, 2023, 7:10AM
IQVIA Forecasts FY23 Revenue Of $14.885B-$14.92B Versus Prior Guidance Of $15.05B-$15.175B And Consensus Of $15.12B
Benzinga Newsdesk
-
Nov 1, 2023, 7:09AM
IQVIA Hldgs Q3 Adjusted EPS $2.49 Beats $2.44 Estimate, Sales $3.74B Miss $3.78B Estimate
Benzinga Newsdesk
-
Nov 1, 2023, 7:02AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch